These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

243 related articles for article (PubMed ID: 1091392)

  • 1. Interaction of physostigmine and delta-9-tetrahydrocannabinol in man.
    Freemon FR; Rosenblatt JE; EL-Yousef MK
    Clin Pharmacol Ther; 1975 Feb; 17(2):121-6. PubMed ID: 1091392
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Interactions in man of delta-9-tetrahydrocannabinol. II. Cannabinol and cannabidiol.
    Hollister LE; Gillespie H
    Clin Pharmacol Ther; 1975 Jul; 18(1):80-3. PubMed ID: 1097148
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Tetrahydrocannabinol and acetylcholinesterase.
    Moss DE; Peck PL; Salome R
    Pharmacol Biochem Behav; 1978 Jun; 8(6):763-5. PubMed ID: 693562
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Comparative pharmacology of Delta9-tetrahydrocannabinol and its metabolite, 11-OH-Delta9-tetrahydrocannabinol.
    Lemberger L; Martz R; Rodda B; Forney R; Rowe H
    J Clin Invest; 1973 Oct; 52(10):2411-7. PubMed ID: 4729039
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Influence of cannabidiol on delta-9-tetrahydrocannabinol effects.
    Dalton WS; Martz R; Lemberger L; Rodda BE; Forney RB
    Clin Pharmacol Ther; 1976 Mar; 19(3):300-9. PubMed ID: 770048
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The interaction of delta9-tetrahydrocannabinol with cholinomimetic drugs in an agonist-antagonist paradigm.
    Jones BC; Consroe PF; Laird HE
    Eur J Pharmacol; 1976 Aug; 38(2):253-9. PubMed ID: 954840
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Cardiovascular effects of cannabinol during oral surgery.
    Gregg JM; Campbell RL; Levin KJ; Ghia J; Elliott RA
    Anesth Analg; 1976; 55(2):203-13. PubMed ID: 769605
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Tolerance to the effect of delta1-tetrahydrocannabinol on corticosterone levels in mouse plasma produced by repeated administration of cannabis extract or delta1-tetrahydrocannabinol.
    Pertwee RG
    Br J Pharmacol; 1974 Jul; 51(3):391-7. PubMed ID: 4451752
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Effects of delta9-tetrahydrocannabinol and cannabinol in man.
    Karniol IG; Shirakawa I; Takahashi RN; Knobel E; Musty RE
    Pharmacology; 1975; 13(6):502-12. PubMed ID: 1221432
    [TBL] [Abstract][Full Text] [Related]  

  • 10. 11-hydroxy- 9 -tetrahydrocannabinol: pharmacology, disposition, and metabolism of a major metabolite of marihuana in man.
    Lemberger L; Crabtree RE; Rowe HM
    Science; 1972 Jul; 177(4043):62-4. PubMed ID: 5041775
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Marihuana-like activity of new synthetic tetrahydrocannabinols.
    Martin BR; Dewey WL; Harris LS; Beckner J
    Pharmacol Biochem Behav; 1975; 3(5):849-53. PubMed ID: 1208625
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The effects of delta-9-tetrahydrocannabinol (cannabis) on cardiac performance with and without beta blockade.
    Kanakis C; Pouget JM; Rosen KM
    Circulation; 1976 Apr; 53(4):703-7. PubMed ID: 1253395
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Cardiovascular effects of prolonged delta-9-tetrahydrocannabinol ingestion.
    Benowitz NL; Jones RT
    Clin Pharmacol Ther; 1975 Sep; 18(3):287-97. PubMed ID: 1164818
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Discriminative response control produced with hashish, tetrahydrocannabinols (delta 8-THC and delta 9-THC), and other drugs.
    Järbe TU; Henriksson BG
    Psychopharmacologia; 1974; 40(1):1-16. PubMed ID: 4445444
    [No Abstract]   [Full Text] [Related]  

  • 15. [Effects of (--)delta-9-trans-tetrahydrocannabinol (delta-9-THC) on tests of psychoticism. A study of Eysenck's drug postulate on the effects of hallucinogens in relation to psychoticism (author's transl)].
    Dittrich A; Bickel P; Zimmer D
    Psychopharmacologia; 1975; 40(4):351-8. PubMed ID: 1096219
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Lack of tolerance to the bradycardic effect of delta 9-trans-tetrahydrocannabinol in rats.
    Kaymakçalan S; Sivil S
    Pharmacology; 1974; 12(4-5):290-5. PubMed ID: 4449891
    [No Abstract]   [Full Text] [Related]  

  • 17. Dimethylheptyl-delta 6a-10a-tetrahydrocannabinol: effects after parenteral administration to man.
    Sidell FB; Pless JE; Neitlich H; Sussman P; Copelan HW; Sim VM
    Proc Soc Exp Biol Med; 1973 Mar; 142(3):867-73. PubMed ID: 4571010
    [No Abstract]   [Full Text] [Related]  

  • 18. Action of delta-9-tetrahydrocannabinol. An approach to the active metabolite hypothesis.
    Hollister LE; Gillespie HK
    Clin Pharmacol Ther; 1975 Dec; 18(6):714-9. PubMed ID: 1204277
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Possible anticholinesterase-like effects of trans(-) 8 and - 9 tetrahydrocannabinol as observed in the general motor activity of mice.
    Brown H
    Psychopharmacologia; 1972; 27(2):111-6. PubMed ID: 4638205
    [No Abstract]   [Full Text] [Related]  

  • 20. Electrocardiographic effects of marihuana.
    Kochar MS; Hosko MJ
    JAMA; 1973 Jul; 225(1):25-7. PubMed ID: 4123475
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 13.